APC 2009 Annual Report Download - page 134
Download and view the complete annual report
Please find page 134 of the 2009 APC annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10
-
11
-
12
-
13
-
14
-
15
-
16
-
17
-
18
-
19
-
20
-
21
-
22
-
23
-
24
-
25
-
26
-
27
-
28
-
29
-
30
-
31
-
32
-
33
-
34
-
35
-
36
-
37
-
38
-
39
-
40
-
41
-
42
-
43
-
44
-
45
-
46
-
47
-
48
-
49
-
50
-
51
-
52
-
53
-
54
-
55
-
56
-
57
-
58
-
59
-
60
-
61
-
62
-
63
-
64
-
65
-
66
-
67
-
68
-
69
-
70
-
71
-
72
-
73
-
74
-
75
-
76
-
77
-
78
-
79
-
80
-
81
-
82
-
83
-
84
-
85
-
86
-
87
-
88
-
89
-
90
-
91
-
92
-
93
-
94
-
95
-
96
-
97
-
98
-
99
-
100
-
101
-
102
-
103
-
104
-
105
-
106
-
107
-
108
-
109
-
110
-
111
-
112
-
113
-
114
-
115
-
116
-
117
-
118
-
119
-
120
-
121
-
122
-
123
-
124
-
125
-
126
-
127
-
128
-
129
-
130
-
131
-
132
-
133
-
134
-
135
-
136
-
137
-
138
-
139
-
140
-
141
-
142
-
143
-
144
-
145
-
146
-
147
-
148
-
149
-
150
-
151
-
152
-
153
-
154
-
155
-
156
-
157
-
158
-
159
-
160
-
161
-
162
-
163
-
164
-
165
-
166
-
167
-
168
-
169
-
170
-
171
-
172
-
173
-
174
-
175
-
176
-
177
-
178
-
179
-
180
-
181
-
182
-
183
-
184
-
185
-
186
-
187
-
188
-
189
-
190
-
191
-
192
-
193
-
194
-
195
-
196
-
197
-
198
-
199
-
200
-
201
-
202
-
203
-
204
-
205
-
206
-
207
-
208
-
209
-
210
-
211
-
212
-
213
-
214
-
215
-
216
-
217
-
218
-
219
-
220
-
221
-
222
-
223
-
224
-
225
-
226
-
227
-
228
-
229
-
230
-
231
-
232
-
233
-
234
-
235
-
236
-
237
-
238
-
239
-
240
-
241
-
242
-
243
-
244
2009 REGISTRATION DOCUMENT SCHNEIDER ELECTRIC132
CONSOLIDATED FINANCIAL STATEMENTS
5NOTES TO THE CONSOLIDATED FINANCIAL STATEMENTS
Note4
Research and development
Research and development costs break down as follows:
2009 2008
Research and development costs in cost of sales 143 161
Research and development costs in commercial expenses 7 16
Research and development costs in R&D costs (1) 403 402
Capitalised development costs 211 195
Total research and development costs of the year 764 774
(1) Of which, EUR 19million research and development tax credit in December2009 and EUR 26million research and development tax
credit in December2008.
Amortisation of capitalised development costs came to EUR 85million in 2009 and EUR 61million in 2008. In addition, exceptional impairment
losses of EUR 4million were recorded on capitalised development costs in 2009, compared with EUR 2million in 2008.
Note5
Depreciation, amortisation and provision expense
Depreciation, amortisation and provision expenses recognised in operating expenses were as follows:
2009 2008
Included in cost of sales:
Depreciation and amortisation (343) (305)
Provisions (10) (38)
Included in selling, general and administrative expenses:
Depreciation and amortisation (130) (147)
Provisions (90) (18)
DEPRECIATION, AMORTISATION AND PROVISION EXPENSE (573) (508)
In 2009, provisions in an amount of EUR 17million were recorded in
other operating income/expense. Impairment of other non-current
assets represented a net charge of EUR 134million, of which
EUR 122million were recorded as goodwill impairment and impairment
of purchase accounting intangibles (note8), and EUR 12million were
recorded in other operating income and expenses (note6).
Note6
Other operating income and expenses
Other operating income and expenses break down as follows:
2009 2008
Impairment losses on non-current assets (12) (9)
Gains on asset disposals 11 17
Losses on asset disposals (17) (7)
US pension plan curtailment 92 -
Others 14 26
OTHER OPERATING INCOME AND EXPENSES 88 27
Gains on asset disposals mainly refl ect the gain on the disposal of
Selectron assets for EUR 8million.
Losses on asset disposals and asset write-offs are primarily related
to the loss on disposal of a Wibe business for EUR 6million and to
an R&D project being terminated for EUR 6million.
The gain of EUR 92million on the US pension plan curtailment is
commented on in note22.